FDA Targets Ineffective Decongestant for Market Removal

The FDA is proposing to remove oral phenylephrine, a common ingredient in over-the-counter cold medicines, from the market due to its ineffectiveness as a nasal decongestant. This follows an advisory panel's conclusion that there is no scientific evidence supporting its efficacy. While phenylephrine is still effective in nasal sprays, its removal from oral medications like Tylenol Cold and Flu and Dayquil could lead to reformulations. The proposal is open for public comment, and the FDA assures that the decision is not based on safety concerns.